Advancing 3D Engineered In Vitro Models for Heart Failure Research: Key Features and Considerations
2024

Advancing 3D Engineered In Vitro Models for Heart Failure Research

publication Evidence: moderate

Author Information

Author(s): van Doorn Elisa C. H., Amesz Jorik H., Manintveld Olivier C., de Groot Natasja M. S., Essers Jeroen, Shin Su Ryon, Taverne Yannick J. H. J.

Primary Institution: Erasmus Medical Center

Hypothesis

The development of three-dimensional engineered in vitro models that closely mimic the (patho)physiology and drug responses of the myocardium has the potential to revolutionize our insights and uncover new therapeutic avenues.

Conclusion

This review details key features of 3D engineered in vitro models for heart failure research, emphasizing their significance in enhancing understanding of the disease and facilitating the development of novel therapies.

Supporting Evidence

  • Heart failure affects 1-3% of the global population and has a high annual mortality rate.
  • Current heart failure treatments focus on symptom management rather than addressing the disease's root causes.
  • Three-dimensional models can replicate the complex environment of the heart better than traditional two-dimensional cultures.

Takeaway

Scientists are creating special 3D models of heart tissue to better understand heart failure and find new treatments.

Methodology

The review discusses the design and features of 3D engineered in vitro models, including aspects like extracellular matrix structure, cell composition, and physiological stimuli.

Limitations

The review does not provide specific experimental data or results from studies but focuses on theoretical aspects and considerations for model development.

Digital Object Identifier (DOI)

10.3390/bioengineering11121220

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication